Personal CFO Solutions LLC Buys 633 Shares of Cabot Co. (NYSE:CBT)

Personal CFO Solutions LLC increased its stake in shares of Cabot Co. (NYSE:CBTFree Report) by 17.4% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,266 shares of the specialty chemicals company’s stock after acquiring an additional 633 shares during the period. Personal CFO Solutions LLC’s holdings in Cabot were worth $356,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Jump Financial LLC bought a new stake in Cabot in the third quarter valued at approximately $291,000. Avantax Advisory Services Inc. bought a new stake in Cabot in the third quarter valued at approximately $253,000. Swiss National Bank raised its stake in Cabot by 0.7% in the third quarter. Swiss National Bank now owns 123,400 shares of the specialty chemicals company’s stock valued at $8,548,000 after buying an additional 800 shares during the period. Charles Schwab Investment Management Inc. raised its stake in Cabot by 3.7% in the third quarter. Charles Schwab Investment Management Inc. now owns 668,796 shares of the specialty chemicals company’s stock valued at $46,327,000 after buying an additional 23,774 shares during the period. Finally, Vanguard Personalized Indexing Management LLC raised its stake in Cabot by 7.9% in the third quarter. Vanguard Personalized Indexing Management LLC now owns 4,494 shares of the specialty chemicals company’s stock valued at $311,000 after buying an additional 328 shares during the period. Institutional investors own 93.18% of the company’s stock.

Cabot Stock Performance

NYSE:CBT opened at $98.10 on Tuesday. The stock has a fifty day moving average price of $97.07 and a 200-day moving average price of $86.72. The company has a market cap of $5.42 billion, a price-to-earnings ratio of 12.42, a PEG ratio of 0.97 and a beta of 1.26. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.47 and a current ratio of 2.24. Cabot Co. has a fifty-two week low of $63.73 and a fifty-two week high of $103.49.

Cabot (NYSE:CBTGet Free Report) last released its earnings results on Monday, May 6th. The specialty chemicals company reported $1.78 earnings per share for the quarter, beating analysts’ consensus estimates of $1.66 by $0.12. The firm had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.04 billion. Cabot had a return on equity of 26.21% and a net margin of 11.51%. The company’s revenue was down 1.4% compared to the same quarter last year. During the same period in the prior year, the company posted $1.33 EPS. As a group, equities analysts anticipate that Cabot Co. will post 6.78 EPS for the current fiscal year.

Cabot Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, June 14th. Stockholders of record on Friday, May 31st will be given a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.75%. This is an increase from Cabot’s previous quarterly dividend of $0.40. The ex-dividend date of this dividend is Friday, May 31st. Cabot’s dividend payout ratio is presently 21.77%.

Insider Activity

In other news, SVP Karen A. Kalita sold 13,764 shares of the company’s stock in a transaction on Friday, May 10th. The stock was sold at an average price of $101.73, for a total transaction of $1,400,211.72. Following the completion of the sale, the senior vice president now directly owns 34,312 shares in the company, valued at approximately $3,490,559.76. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 3.07% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on CBT. Mizuho increased their target price on Cabot from $104.00 to $109.00 and gave the stock a “buy” rating in a research note on Tuesday, May 7th. StockNews.com upgraded Cabot from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, May 8th. UBS Group increased their target price on Cabot from $100.00 to $103.00 and gave the stock a “neutral” rating in a research note on Tuesday, May 7th. Finally, Deutsche Bank Aktiengesellschaft lowered Cabot from a “buy” rating to a “hold” rating and increased their target price for the stock from $88.00 to $95.00 in a research note on Thursday, April 18th. Three investment analysts have rated the stock with a hold rating, two have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $93.67.

Read Our Latest Stock Report on CBT

About Cabot

(Free Report)

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

Featured Articles

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Co. (NYSE:CBTFree Report).

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.